Faculty who have authored publication Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.
Name | Title | Department | Institution |
---|---|---|---|
Christopher J. Schultz MD | Chair, Professor | Radiation Oncology | Medical College of Wisconsin |